Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany

被引：23
作者：
Fluegge, K
Supper, S
Siedler, A
Berner, R
机构：
[1] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany
[2] Robert Koch Inst, D-1000 Berlin, Germany
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 11期
关键词：
D O I：
10.1128/AAC.48.11.4444-4446.2004
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The antimicrobial susceptibility of 296 invasive neonatal group B streptococcus isolates from a nationwide 2-year surveillance study in Germany was investigated. All isolates were susceptible to beta-lactams, linezolid, quinupristin-dalfopristin, and vancomycin. Erythromycin and clindamycin resistance was found in 10.1 and 5.7%, respectively. The ermB, ermTR, or mefA gene was detected in all but one of the erythromycin-resistant isolates.
引用
收藏
页码：4444 / 4446
页数：3
相关论文
共 31 条
[21]   Ertapenem: a new carbapenem [J].
Odenholt, I .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (06) :1157-1166
[22]   In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae [J].
Patel, R ;
Rouse, MS ;
Piper, KE ;
Steckelberg, JM .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (02) :119-122
[23]   Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin [J].
Pearlman, MD ;
Pierson, CL ;
Faix, RG .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (02) :258-261
[24]   Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital [J].
Poyart, C ;
Jardy, L ;
Quesne, G ;
Berche, P ;
Trieu-Cuot, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :794-797
[25]   Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001 [J].
Reinert, RR ;
Lütticken, R ;
Bryskier, A ;
Al-Lahham, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :489-493
[26]   Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants [J].
Roberts, MC ;
Sutcliffe, J ;
Courvalin, P ;
Jensen, LB ;
Rood, J ;
Seppala, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :2823-2830
[27]   Antibiotic susceptibility profile of group B streptococcus acquired vertically [J].
Rouse, DJ ;
Andrews, WW ;
Lin, FYC ;
Mott, CW ;
Ware, JC ;
Philips, JB .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (06) :931-934
[28]   Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis [J].
Schrag, SJ ;
Zywicki, S ;
Farley, MM ;
Reingold, AL ;
Harrison, LH ;
Lefkowitz, LB ;
Hadler, JL ;
Danila, R ;
Cieslak, PR ;
Schuchat, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (01) :15-20
[29]   Group B streptococcus [J].
Schuchat, A .
LANCET, 1999, 353 (9146) :51-56
[30]  
Seppälä H, 1998, ANTIMICROB AGENTS CH, V42, P257
1234